Cellife NAD II

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

ferrous fumarate, Quantity: 25 mg (Equivalent: iron, Qty 8 mg); nicotinamide, Quantity: 10 mg; manganese amino acid chelate, Quantity: 35 mg (Equivalent: manganese, Qty 3.5 mg); cyanocobalamin, Quantity: 0.0024 mg; leucine, Quantity: 100 mg; heavy magnesium oxide, Quantity: 100 mg (Equivalent: magnesium, Qty 60 mg); nicotinic acid, Quantity: 100 mg; calcium gluconate monohydrate, Quantity: 225 mg (Equivalent: calcium, Qty 20 mg); quercetin, Quantity: 13 mg; menaquinone 7, Quantity: 0.06 mg; Cinnamomum cassia, Quantity: 50 mg (Equivalent: Cinnamomum cassia, Qty 500 mg; Equivalent: coumarin, Qty 0.001 mg); Reynoutria japonica, Quantity: 30 mg (Equivalent: Reynoutria japonica, Qty 300 mg); zinc glycinate, Quantity: 29 mg (Equivalent: zinc, Qty 8 mg)

Disponibbli minn:

Cellife Health Products Pty Ltd

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: microcrystalline cellulose; isomalt; magnesium stearate; colloidal anhydrous silica; mannitol

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Helps reduce/decrease free radical damage to body cells ; Helps improve/promote body metabolism/metabolic rate ; Maintain/support body tissue repair/regeneration

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Listed

Data ta 'l-awtorizzazzjoni:

2019-08-21